MI
AKTX

MMCAP International’s Akari Therapeutics AKTX Stock Holding History

MMCAP International’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
+100,000
New +$863K 0.09% 138

Other funds holding AKTX

CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return

MMCAP International's AKTX Position: Q2 2026 in Review

MMCAP International opened a new position in Akari Therapeutics (AKTX) in Q2 2026: 100,000 shares worth $1.02M. The stake represents 0.09% of the portfolio and ranks #138 among its holdings.

9 funds tracked by Wall St. Rank hold AKTX as of Q2 2026.

  • MMCAP International held 100,000 shares of Akari Therapeutics worth $1.02M as of Q2 2026.
  • Akari Therapeutics was a new MMCAP International position in Q2 2026.
  • Akari Therapeutics made up 0.09% of MMCAP International's portfolio in Q2 2026, its #138 holding.
  • 9 funds tracked by Wall St. Rank held Akari Therapeutics as of Q2 2026.

Based on MMCAP International's 13F filing for Q2 2026, filed 14 Aug 2026.